Two smaller feasibility trials19, 20 investigating blood pressure targets after cardiac arrest did not demonstrate a difference in biomarker neuron‐specific enolase (NSE) levels that were used as a surrogate outcome measure of brain injury. The gene discussed is ENO2; the disease is brain injury.